Home/Filings/4/0001562180-23-002404
4//SEC Filing

Obenshain Andrew 4

Accession 0001562180-23-002404

CIK 0001293971other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 4:43 PM ET

Size

7.2 KB

Accession

0001562180-23-002404

Insider Transaction Report

Form 4
Period: 2023-03-01
Obenshain Andrew
DirectorPresident and CEO
Transactions
  • Award

    Common Stock

    2023-03-01+67,600308,870 total
  • Award

    Stock Option (right to buy)

    2023-03-01+338,000338,000 total
    Exercise: $5.11Exp: 2033-03-01Common Stock (338,000 underlying)
Footnotes (2)
  • [F1]Restricted stock unit awards vest over a four-year period at the rate of 25% on 01/03/2024, 25% on 01/03/2025, 25% on 01/03/2026, and 25% on 01/03/2027.
  • [F2]This stock option vests over a four-year period at the rate of 25% on 01/03/2024 and then in 36 equal monthly installments thereafter

Issuer

bluebird bio, Inc.

CIK 0001293971

Entity typeother

Related Parties

1
  • filerCIK 0001839697

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:43 PM ET
Size
7.2 KB